Rockwell Medical (RMTI) Cost of Revenue (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cost of Revenue came in at $14.4 million in Q1 2026, down 9.03% YoY from $15.9 million in Q1 2025, and little changed on a QoQ basis from $14.5 million in Q4 2025.
Rockwell Medical (RMTI) Cost of Revenue (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Cost of Revenue data on file, last reported at $14.4 million in Q1 2026.
- Quarterly Cost of Revenue fell 9.03% year-over-year to $14.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.1 million (down 30.07% YoY) and the FY2025 annual result came in at $57.6 million, down 31.48% from the prior year.
- Cost of Revenue steadied at $14.4 million in Q1 2026, from $14.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $22.1 million in Q3 2024 to a low of $13.6 million in Q2 2025.
- A 5-year average of $17.6 million and a median of $17.0 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2024 — Cost of Revenue gained 24.84% — and 2025, when it plunged 38.15%.
- Tracing RMTI's Cost of Revenue over 5 years: stood at $17.0 million in 2022, then gained by 13.26% to $19.2 million in 2023, then grew by 9.42% to $21.0 million in 2024, then slumped by 31.22% to $14.5 million in 2025, then declined by 0.2% to $14.4 million in 2026.
- The last three Cost of Revenue figures came in at $14.4 million (Q1 2026), $14.5 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Rockwell Medical | 29.69 Mn | 4.89 Mn | 3.24 Mn | 14.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.54 Mn |
| Jun 30, 2026 | 14.54 Mn |
| Mar 31, 2026 | 14.44 Mn |
| Mar 31, 2026 | 14.44 Mn |
| Dec 31, 2025 | 14.47 Mn |
| Dec 31, 2025 | 14.47 Mn |
| Sep 30, 2025 | 13.66 Mn |
| Sep 30, 2025 | 13.66 Mn |
| Jun 30, 2025 | 13.57 Mn |
| Jun 30, 2025 | 13.57 Mn |
| Mar 31, 2025 | 15.87 Mn |
| Mar 31, 2025 | 15.87 Mn |
| Dec 31, 2024 | 21.03 Mn |
| Dec 31, 2024 | 21.03 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Sep 30, 2024 | 22.08 Mn |
| Jun 30, 2024 | 21.28 Mn |
| Jun 30, 2024 | 21.28 Mn |
| Mar 31, 2024 | 19.61 Mn |
| Mar 31, 2024 | 19.61 Mn |